MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202511005401 A) filed by Mankind Pharma Ltd. on January 23, 2025, for A Process Of Preparing Latanoprostene Bunod Ophthalmic Composition.
Inventors include Jaiswal, Chandra Prakash; Kumar, Mukesh; Upadhyay, Satish Chandra; and Kumar, Anil.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present invention relates to a process for the preparation of an aqueous ophthalmic composition comprising Latanoprostene bunod or its salts thereof along with one or more pharmaceutically acceptable excipients. Further, the present invention also relates to an aqueous ophthalmic composition comprising Latanoprostene bunod or its salts thereof along with one or more pharmaceutically acceptable excipients used for the reduction of intraocular pressure associated with open-angle glaucoma or ocular hypertension. Dated this, 23rd day of January, 2025 For Mankind Pharma Ltd. Dr. Anil Kumar Chief Scientific Officer
Disclaimer: Curated by HT Syndication.
